This inventor holds 2 USPTO granted patents. Top assignee: Sanofi-Synthelabo. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Innovator Zsuzsanna Nád: Pioneering Contributions to Pharmaceutical Chemistry
Introduction: Zsuzsanna Nád, an accomplished inventor based in Budapest, Hungary, has made significant strides in the field of pharmaceutical chemistry with her innovative contributions. With a focus on developing intermediates for key therapeutic compounds, her work showcases the intersection of creativity and scientific rigor in the pursuit of advancing healthcare.
Latest Patents: Zsuzsanna holds two patents that address critical processes in the synthesis of angiotensin II antagonists. Her latest patents include a detailed method for the preparation of 1,3-diaza-spiro (4.4) non-1-en-4-one derivatives and 1-cyano-1-acylamino-cyclopentane intermediates. These patents outline sophisticated processes involving various chemical reactions, such as the transformation of compounds in the presence of oxidizing agents in alkaline conditions, enabling the production of essential pharmaceutical intermediates.
Career Highlights: Zsuzsanna is a valued member of the Sanofi-Synthelabo team, where her expertise contributes to innovative drug development. Her patents reflect the advanced methodologies she employs to synthesize complex organic molecules that are crucial in producing new therapeutic agents. Through her work, she exemplifies dedication to improving health outcomes through chemistry.
Collaborations: In her career, Zsuzsanna has collaborated with esteemed colleagues, including Attila Kis-Tamás and Csaba Huszár. Their combined expertise fosters a collaborative environment that drives forward-thinking approaches in pharmaceutical research and development.
Conclusion: Zsuzsanna Nád stands out as a notable inventor whose work in pharmaceutical chemistry continues to pave the way for advancements in medicinal science. With her innovative approaches and collaborative spirit, she embodies the qualities of a modern inventor dedicated to enhancing healthcare through inventive solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
